Humira Sucks Customer Reviews and Feedback
Adalimumab, sold under the brand name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis. Use is generally only recommended in people who have not responded to other treatments. It is used by injection under the skin.
A former employee said this in a review: " Humira (Adalimumab) has gone through multiple changes over the years and the company has gotten worse as a result. There are very little opportunities to grow your career. Internal hiring managers and HR don't care about any of the internal or external training courses completed."
Former Employee - Pharmacy Technician says"I worked at AbbVie full-time for more than 10 years Cons: They may preach about how well they treat patients on Humira and Lupron (not entirely true) but they are awful to employees, even long time employees who fall ill, even with same indications as their patients. I have been in and out of specialist offices, having surgeries and returning to work never been treated so poorly. I've been harrassed for taking to long in the washroom, using washroom too much, and I've had notes from Dr's asking to please excuse due to nature of surgery. The notes went ignored. Having over lapping illnesses endometriosis, polycystic ovarian disease, degenerative disc disease and Hidrenitis Supperveda puts enough stress on a body. But coming back to work from medical leave to be put on a performance plan because my call score fluctuated in the 90's was harsh. Fired two days after my 16 year anniversary."
Former Contractor - Clinical Research Associate says"I worked at AbbVie for more than a year Cons: Very money driven, focussed everything on Humira"
Current Employee - Professional says"I have been working at AbbVie full-time for more than a year Cons: Around 80% of employees are women who play emotional and tormenting games which contributes to high levels of stress, bullying and politics. Lots of favoritism 'jobs for the girls'', Terribly bad 'old school' and reactive HR partnering that also contributes to the politics. Company is even now still finding it's feet and paralyzed by processes which are mostly broken, toxic environment, employees are highly ambitious females therefore it's dog eat dog and the development/promotion opportunities are dwindling due to growth slowing. Pipeline is full of small oncology products that won't replace the revenue of Humira, belt tightening cost cutting exercises occurring all around, employees disengaged and many talking of leaving. Slowly but surely slipping down the list of Great Place to Work for the reasons above. (2015, 10th place, 2016, 14th place and 2017 18th place.. will be interesting to see if they even appear on the list next year as they start to downsize and the bonuses shrink along with employee engagement). Humira is the main and almost only product it is facing patient expiry, the bio-similars are coming it's time for us to leave the sinking ship!"
says"I have been working at AbbVie Cons: lack of developmental opportunites Too much exposure to HUMIRA \ Can we get anything to lauch out of our pipeline? Conflicing directions -- be a lean, decisive biopharmaceutical company and yet we just signed a CIA"
Current Employee - Anonymous Employee says"I have been working at AbbVie full-time Cons: Heavy focus on immunology (Humira), not very diversified"
Former Employee - Anonymous Employee says"I worked at AbbVie full-time for more than 10 years Cons: Management transparency; overpays for L&A; lots of positions disappearing as Humira patent protection looms; many groups waiting for next re-org to see who's still there; company claims to be "biopharm" but only big pharma in sr. management positions."
Scientist I says"I worked at AbbVie Cons: Very high stress place to work right now due to Humira coming off patent soon with the smell of desperation in the air. Huge discrepancies in pay and benefits from top to bottom."
Former Employee - Associate Director of Marketing says"I worked at AbbVie full-time for more than 10 years Cons: As products reach end of life, fear factor of layoffs is high. I went through numerous redeployments as products reached patent cliff. Half of the revenue is now focused on Humira and creating a lot of stress on employees."
Former Employee - Anonymous Employee says"I worked at AbbVie full-time Cons: Still living in the old Humira days with ‘this is how we used to do it’ mentality. Got very greedy. Sadly the management is all over the place and no identity lost its ‘culture’. Have a very hire and fire mentality with very little consideration for human beings. (Yes a bitter aftertaste!)"
Current Employee - Anonymous Employee says"I have been working at AbbVie full-time Cons: Arrival of Biosimilar will impact massively its revenue from the blockbuster Humira in the next 18 months Reshaping its european structure, many jobs will probably disappear Not as innovative as other big pharma reinventing Integrated solutions beyond the pill"
Kalah Love says"@realCOVID19_ I can’t take methotrexate, tried Humira & one other new med ? that my brain can’t remember right now.… https://t.co/asLX9ngqY4"
???Annabeth #PissedOffGoldStarDaughter??? says"PANDEMIC “JOYS”: Vasculitis SUCKS! Rheumatoid? Cutaneous? Went off Humira (back on now w/ new research) beginning o… https://t.co/DwCSoz6q4T"
Barry Anderson says"Kinda sucks when there’s painful medication and pain-free and the company is like, nah, you guys only get the painf… https://t.co/UBQiASWnZ5"
Kelly Davis says"@lylldy @chipcoffey @humira Stay healthy ❤️"
In The News
Ankylosing Spondylitis News reports"Lower Levels of Humira and Having Autoantibodies Predict Treatment Failure, Study Says"
Law.com reports"How AbbVie and Humira Avoided 'Pay for Delay' Finding | National Law Journal"
The National Law Review reports"AbbVie Humira Patent Thicket Not Providing Cognizable Basis for Antitrust Violation"
Motley Fool reports"Is AbbVie Stock a Buy?"